1 – 35 of 35
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The effects and possible mechanism of action of apolipoprotein M on the growth of breast cancer cells
(
- Contribution to journal › Article
- 2021
-
Mark
Apolipoprotein M promotes cholesterol uptake and efflux from mouse macrophages
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system
(
- Contribution to journal › Scientific review
-
Mark
Apolipoprotein m promotes growth and inhibits apoptosis of colorectal cancer cells through upregulation of ribosomal protein s27a
(
- Contribution to journal › Article
- 2020
-
Mark
Apolipoprotein M overexpression through adeno-associated virus gene transfer improves insulin secretion and insulin sensitivity in Goto-Kakizaki rats
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M : Research Progress and Clinical Perspective
(
- Contribution to journal › Article
-
Mark
Increased expression levels of inflammatory cytokines and adhesion molecules in lipopolysaccharide‑induced acute inflammatory apoM‑/‑ mice
(
- Contribution to journal › Article
-
Mark
Comprehensive lipidomics in apoM−/− mice reveals an overall state of metabolic distress and attenuated hepatic lipid secretion into the circulation
(
- Contribution to journal › Article
-
Mark
Insulin resistance in apolipoprotein M knockout mice is mediated by the protein kinase akt signaling pathway
(
- Contribution to journal › Article
- 2019
-
Mark
Apolipoprotein M could inhibit growth and metastasis of SMMC7721 cells via vitamin D receptor signaling
(
- Contribution to journal › Article
-
Mark
Negative correlation between serum levels of homocysteine and apolipoprotein M
(
- Contribution to journal › Article
-
Mark
Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M induces inhibition of inflammatory responses via the S1PR1 and DHCR24 pathways
(
- Contribution to journal › Article
- 2018
-
Mark
Apolipoprotein M promotes proliferation and invasion in non-small cell lung cancers via upregulating S1PR1 and activating the ERK1/2 and PI3K/AKT signaling pathways
(
- Contribution to journal › Article
-
Mark
Increased apolipoprotein M induced by lack of scavenger receptor BI is not activated via HDL-mediated cholesterol uptake in hepatocytes
(
- Contribution to journal › Article
- 2017
-
Mark
17β-estradiol regulates the expression of apolipoprotein M through estrogen receptor α-specific binding motif in its promoter
(
- Contribution to journal › Article
-
Mark
Apolipoprotein M increases the expression of Vitamin D receptor mRNA in colorectal cancer cells detected with duplex fluorescence reverse transcription-quantitative polymerase chain reaction
(
- Contribution to journal › Article
- 2016
-
Mark
Familial hypercholesterolaemia : cholesterol efflux and coronary disease
(
- Contribution to journal › Article
- 2012
-
Mark
Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL
(
- Contribution to journal › Article
-
Mark
ABCA1 upregulating apolipoproein M expression mediates via the RXR/LXR pathway in HepG2 cells
(
- Contribution to journal › Article
- 2011
-
Mark
Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor
(
- Contribution to journal › Article
-
Mark
TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells
(
- Contribution to journal › Article
-
Mark
Expression of apolipoprotein M in human hepatocellular carcinoma tissues
(
- Contribution to journal › Article
-
Mark
Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects
(
- Contribution to journal › Letter
- 2010
-
Mark
Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus
(
- Contribution to journal › Article
- 2009
-
Mark
Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness
(
- Contribution to journal › Article
- 2008
-
Mark
Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro
(
- Contribution to journal › Article
- 2007
-
Mark
Hyperglycernia down-regulates apolipoprotein M expression in vivo and in vitro
(
- Contribution to journal › Article
- 2006
-
Mark
Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells.
(
- Contribution to journal › Article
- 2005
-
Mark
Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells.
(
- Contribution to journal › Article
- 2004
-
Mark
Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
(
- Contribution to journal › Article
-
Mark
Expression pattern of apolipoprotein M during mouse and human embryogenesis
(
- Contribution to journal › Article
-
Mark
Characterization of apoM in normal and genetically modified mice
(
- Contribution to journal › Article
- 2003
-
Mark
Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization
(
- Contribution to journal › Article
- 2001
-
Mark
Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis
(
- Contribution to journal › Article